about
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasiaWorldwide burden of cervical cancer in 2008.Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseClinical malaria in African pregnant women.Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.Human papillomavirus prevalence and type distribution in penile carcinoma.Global burden of human papillomavirus and related diseases.Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.[Human papillomavirus vaccine. Efficacy and safety].Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.Hepatitis C infection and lymphomas: is there any benefit in viral treatment?Using HPV prevalence to predict cervical cancer incidence.HPV-FASTER: broadening the scope for prevention of HPV-related cancer.Epidemiology and burden of HPV-related disease.Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).Solid organ transplantation and response to vaccination.GAVI ReportValidación del modelo probabilístico EuroSCORE en pacientes intervenidos de injerto coronarioVaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policiesAnálisis del coste del trasplante cardíaco en un hospital español
P50
Q28296557-EE75EA4B-0A4E-40FF-BB0D-4665AB683E67Q34176394-A9EB2F7C-BC08-4255-8B5A-902E0E41DE84Q34642665-8A81E490-F124-4D8D-B408-4D517C3AE14CQ36194955-170505EA-0766-477D-9ECB-339BB0A50FD3Q36496472-0B5DBC05-3D09-4357-B8CE-1CDE8771E5ABQ36560944-09C785CD-EF51-4045-A7B4-56329D4717E2Q37586655-71737B58-654A-45F2-BF21-5253759708ADQ38064060-9CEED66A-E7D0-4DB1-A64D-B0ED766FEC9CQ38170707-985BB4AB-0740-4B92-8404-BFAF242434E6Q38848935-1A5FB747-91F9-4B42-AE22-AA05A678280DQ39818684-2E5F31E4-A39F-4569-9FC9-16AD182A5864Q40523544-06E8169B-787B-46C3-95E2-163725B438D9Q41262416-EF12C6C3-ADA3-4730-82F0-ED2C0DC66114Q43596600-E9F9F539-3729-4105-A560-DBDFF3104F4BQ44559852-542152E6-BA1B-4BB7-9626-20A3FC0C0B24Q45389299-BB1FA955-DAE7-4753-B70A-5078E7B583A8Q46902171-64B5DC5C-E339-4E8D-ABCC-8ECC047A7709Q47742105-A890CCE8-5C5B-408C-A2F1-B8129CC7051EQ51190520-9B86FDD5-7C74-447F-82FF-FE33D44B15DEQ51905361-78549B05-7BC1-4B8D-A3B4-147E8F17369FQ58023922-2AC7D950-4191-4C17-B0C8-0B3DC666ED94Q58870130-DAC92B3A-5D83-44A7-8DE8-7AEB253E36B0Q58870132-499A90F7-8C6A-45F7-9832-F441922CFBA1Q58870134-726651E5-C9C2-489E-B1D2-1E8F3684E152
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laia Bruni
@ast
Laia Bruni
@en
Laia Bruni
@es
Laia Bruni
@nl
Laia Bruni
@sl
type
label
Laia Bruni
@ast
Laia Bruni
@en
Laia Bruni
@es
Laia Bruni
@nl
Laia Bruni
@sl
prefLabel
Laia Bruni
@ast
Laia Bruni
@en
Laia Bruni
@es
Laia Bruni
@nl
Laia Bruni
@sl
P106
P21
P31
P496
0000-0003-3943-0326